insights_auto
Nega BRM oshdi 2,10%?
Batafsil oʻrganishchevron_right
BRM:FRA
Bristol Myers Squibb
51,53 €
arrow_upward
+2,10%(+1,06) 1K
14-okt, 15:47:09 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBRM tikeri uchun statistika yaratilmoqda...
Ochish
50,51 €
Yuqori
51,53 €
Past
50,51 €
Bozor kapitali
121,09 mlrd
Oʻrtacha hajm
224,00
Hajmi
40,00
52 haftalik eng yuqori
60,64 €
52 haftalik eng past
36,65 €
Xodimlar soni
32 ming
Ochish
50,51 €
Yuqori
51,53 €
Past
50,51 €
Bozor kapitali
121,09 mlrd
Oʻrtacha hajm
224,00
Hajmi
40,00
52 haftalik eng yuqori
60,64 €
52 haftalik eng past
36,65 €
Xodimlar soni
32 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
MarketBeat
·
14 daqiqa oldin
Bristol Myers Squibb (NYSE:BMY) Shares Up 4% - What's Next?
ad-hoc-news.de
·
6 soat oldin
Wells Fargo cuts target for Bristol Myers Squibb stock to USD 60.00
Yahoo Finance
·
8 soat oldin
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It
BioSpace
·
10 soat oldin
J&J’s disappointing Q3, RevMed’s subgroup data, BMS’ ‘mixed’ results, Caribou’s cutback
Profil
Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2025, 69% of the company's revenues came from the United States.
The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000. Wikipedia
Bristol Myers Squibb haqida
CEOChris Boerner
Xodimlar soni32,5 ming
Asos solingan1887
Bosh ofislarNyu-York shahri, Nyu-York, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytbms.com